AGARWAL, T.; ANNAMALAI, N.; RONANKI, H. P.; BUTTY, S.; MAITI, T. K.; ARSAD, H. B. MUTANT P21 PEPTIDES COULD ACT AS AN IMPROVED CYCLIN A INHIBITORS FOR CANCER THERAPY: AN IN SILICO VALIDATION. International Journal of Pharmacy and Pharmaceutical Sciences, [S. l.], v. 11, n. 2, p. 59–64, 2019. DOI: 10.22159/ijpps.2019v11i2.30577. Disponível em: https://mail.innovareacademics.in/journals/index.php/ijpps/article/view/30577. Acesso em: 5 nov. 2024.